Cargando…

Relevance of Bacteriophage 933W in the Development of Hemolytic Uremic Syndrome (HUS)

Hemolytic uremic syndrome (HUS), principally caused by shiga toxins (Stxs), is associated with Shiga toxin-producing Escherichia coli (STEC) infections. We previously reported Stx2 expression by host cells in vitro and in vivo. As the genes encoding the two Stx subunits are located in bacteriophage...

Descripción completa

Detalles Bibliográficos
Autores principales:	Del Cogliano, Manuel E., Pinto, Alipio, Goldstein, Jorge, Zotta, Elsa, Ochoa, Federico, Fernández-Brando, Romina Jimena, Muniesa, Maite, Ghiringhelli, Pablo D., Palermo, Marina S., Bentancor, Leticia V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6300567/ https://www.ncbi.nlm.nih.gov/pubmed/30619183 http://dx.doi.org/10.3389/fmicb.2018.03104

Ejemplares similares

Development of camelid single chain antibodies against Shiga toxin type 2 (Stx2) with therapeutic potential against Hemolytic Uremic Syndrome (HUS)
por: Mejías, Maria P., et al.
Publicado: (2016)

Eculizumab in Typical Hemolytic Uremic Syndrome (HUS) With Neurological Involvement
por: Pape, Lars, et al.
Publicado: (2016)

Treatment and outcome of Shiga-toxin-associated hemolytic uremic syndrome (HUS)
por: Scheiring, Johanna, et al.
Publicado: (2008)

Pregnancy-triggered atypical hemolytic uremic syndrome (aHUS): a Global aHUS Registry analysis
por: Fakhouri, Fadi, et al.
Publicado: (2021)

Antibody Response to Shiga Toxins in Argentinean Children with Enteropathic Hemolytic Uremic Syndrome at Acute and Long-Term Follow-Up Periods
por: Fernández-Brando, Romina J., et al.
Publicado: (2011)

Treatment of enterohemorrhagic Escherichia coli (EHEC) infection and hemolytic uremic syndrome (HUS)
por: Goldwater, Paul N, et al.
Publicado: (2012)

Atypical Hemolytic Uremic Syndrome: Differential Diagnosis from TTP/HUS and Management
por: Yenerel, Mustafa N.
Publicado: (2014)

Role of bacteriophages in STEC infections: new implications for the design of prophylactic and treatment approaches
por: Amorim, Jaime H., et al.
Publicado: (2014)

Cationic Antimicrobial Peptides Inactivate Shiga Toxin-Encoding Bacteriophages
por: Del Cogliano, Manuel E., et al.
Publicado: (2017)

Hemoconcentration and predictors in Shiga toxin-producing E. coli-hemolytic uremic syndrome (STEC-HUS)
por: Loos, Sebastian, et al.
Publicado: (2021)

Prognostic utility of ADAMTS13 activity for the atypical hemolytic uremic syndrome (aHUS) and comparison of complement serology between aHUS and thrombotic thrombocytopenic purpura
por: Oh, Jisu, et al.
Publicado: (2019)

Combined Action of Shiga Toxin Type 2 and Subtilase Cytotoxin in the Pathogenesis of Hemolytic Uremic Syndrome
por: Álvarez, Romina S., et al.
Publicado: (2021)

Atypical hemolytic uremic syndrome (aHUS) responsive to mycophenolate mofetil: A case report from Nepal
por: Gurung, Jyoti, et al.
Publicado: (2022)

Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS): a 24-year clinical experience with 178 patients
por: Levandovsky, Mark, et al.
Publicado: (2008)

Reduced dose maintenance eculizumab in atypical hemolytic uremic syndrome (aHUS): an update on a previous case report
por: Ohanian, Maro, et al.
Publicado: (2011)

Baseline characteristics and evolution of Brazilian patients with atypical hemolytic uremic syndrome: first report of the Brazilian aHUS Registry
por: Vaisbich, Maria Helena, et al.
Publicado: (2022)

Nasal immunization with H7 flagellin protects mice against hemolytic uremic syndrome secondary to Escherichia coli O157:H7 gastrointestinal infection
por: Bernal, Alan Mauro, et al.
Publicado: (2023)

Determinants of Bacteriophage 933W Repressor DNA Binding Specificity
por: Bullwinkle, Tammy J., et al.
Publicado: (2012)

An Atypical Case of Shiga Toxin Producing-Escherichia Coli Hemolytic and Uremic Syndrome (STEC-HUS) in a Lung Transplant Recipient
por: Manière, Louis, et al.
Publicado: (2019)

Early Eculizumab Withdrawal in Patients With Atypical Hemolytic Uremic Syndrome in Native Kidneys Is Safe and Cost-Effective: Results of the CUREiHUS Study
por: Bouwmeester, Romy N., et al.
Publicado: (2022)

Soluble CD40 Ligand and Oxidative Response Are Reciprocally Stimulated during Shiga Toxin-Associated Hemolytic Uremic Syndrome
por: Abrey Recalde, Maria J., et al.
Publicado: (2017)

Clinical characteristics and outcomes of a patient population with atypical hemolytic uremic syndrome and malignant hypertension: analysis from the Global aHUS registry
por: Halimi, Jean-Michel, et al.
Publicado: (2022)

Role of Polymorphonuclear Leukocytes in the Pathophysiology of Typical Hemolytic Uremic Syndrome
por: Exeni, Ramón A., et al.
Publicado: (2007)

Hemolytic uremic syndrome.
por: Beers, M, et al.
Publicado: (1995)

2295. Streptococcus pneumoniae-Related Hemolytic Uremic Syndrome (pHUS) and the Identification of Matched Cross Country Serotypes by Plasma Next-Generation Sequencing (NGS)
por: Yonts, Alexandra, et al.
Publicado: (2018)

Editorial: Shiga Toxin-Converting Bacteriophages
por: Węgrzyn, Grzegorz, et al.
Publicado: (2021)

Eculizumab, SARS-CoV-2 and atypical hemolytic uremic syndrome
por: Trimarchi, Hernán, et al.
Publicado: (2020)

Clinical aspects of a nationwide epidemic of severe haemolytic uremic syndrome (HUS) in children
por: Krogvold, Lars, et al.
Publicado: (2011)

Atypical hemolytic uremic syndrome
por: Loirat, Chantal, et al.
Publicado: (2011)

Recurrent hemolytic uremic syndrome
por: Lakshminarayana, G., et al.
Publicado: (2008)

Atypical Hemolytic Uremic Syndrome
por: Kavanagh, David, et al.
Publicado: (2013)

Management of hemolytic uremic syndrome
por: Kavanagh, David, et al.
Publicado: (2014)

Postinfectious Hemolytic Uremic Syndrome
por: Bitzan, Martin, et al.
Publicado: (2016)

Hemolytic Uremic Syndrome in Children
por: Gülhan, Bora, et al.
Publicado: (2021)

Interferon beta-1b-induced thrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS) in a patient treated for multiple sclerosis: A case report
por: Etemadifar, Masoud, et al.
Publicado: (2018)

Atypical Hemolytic Uremic Syndrome (aHUS) and Adenosine Deaminase (ADA)-Deficient Severe Combined Immunodeficiency (SCID)—Two Diseases That Exacerbate Each Other: Case Report
por: Bogdał, Anna, et al.
Publicado: (2021)

Promoter Sequence of Shiga Toxin 2 (Stx2) Is Recognized In Vivo, Leading to Production of Biologically Active Stx2
por: Bentancor, Leticia V., et al.
Publicado: (2013)

Functional Capacity of Shiga-Toxin Promoter Sequences in Eukaryotic Cells
por: Bentancor, Leticia V., et al.
Publicado: (2013)

Exploratory Prognostic Biomarkers of Complement-Mediated Thrombotic Microangiopathy (CM-TMA) in Adults with Atypical Hemolytic Uremic Syndrome (aHUS): Analysis of a Phase III Study of Ravulizumab
por: Cammett, Tobin J., et al.
Publicado: (2022)

Drug-induced hemolytic uremic syndrome
por: Cavoli, G. Li, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_7dg7ac41u8ub8o5oc4tltjehl3